The Supreme Court questioned inflated medicine prices at corporate hospitals, particularly when patients are required to buy drugs from in-house pharmacies. The bench noted that high costs under govt healthcare schemes ultimately burden taxpayers. It also questioned large gaps between retailer prices and MRPs and sought the Centre's response on pricing controls.
Telangana
Supreme Court Flags Inflated Medicine Prices
